Snapshot Highlights
- Pioneering Gynecologic Oncology Specialist
- Extensive experience in Menopause and Endometriosis Treatment
- Expertise in Pelvic Pain Management
- Published researcher in prominent gynecologic oncology journals
- Affiliated with leading healthcare institutions
M.FARUK KOSE
Professional Experience
Dr. M. Faruk Kose brings over three decades of dedicated medical practice to the field of Gynecologic Oncology and Obstetrics. His career, which began in 1981, has been marked by progressive leadership roles and a deep commitment to patient care and advancing gynecological health. From 2020, he has been a valued member of the Acıbadem Health Group. Prior to this, his impactful tenure included serving as a Specialist in Gynecological Oncology Surgery at Medipol Mega University Hospital from 2014 to 2016. He also led the Gynecology and Obstetrics Clinic at LIV Hospital Ulus as Clinic Director from 2012 to 2014, and was the Medical Director at Universal Italian Giovanni Alberto Agnelli Hospital from 2011 to 2012. Dr. Kose demonstrated significant leadership as the Chief of the Gynecological Oncology Clinic at Etlik Zübeyde Hanım Gynecology and Obstetrics Training and Research Hospital from 2005 to 2011, and previously as Chief of the Gynecological Oncology Clinic at Ankara Maternity and Gynecology Training Hospital from 1992 to 2005. His foundational experience as a Specialist Physician was also at Ankara Maternity and Gynecology Training Hospital from 1988 to 1992.
Education and Board Certification
Dr. Kose’s academic foundation is robust, stemming from his graduation from Hacettepe University Faculty of Medicine in 1981. He further honed his medical expertise at Ankara University Faculty of Medicine, Department of Obstetrics and Gynaecology, completing his specialization in 1988. His commitment to advanced surgical techniques and specialized oncology care is underscored by his achievement of the Medical Specialization Board in Gynecological Oncology Surgery in 2011.
Areas of Clinical Focus
Dr. Kose’s expertise encompasses a comprehensive range of gynecological health concerns. He is a recognized specialist in Gynecologic Oncology, dedicated to the diagnosis and treatment of cancers affecting the female reproductive system. His practice also focuses on general Gynecology and Obstetrics, addressing a broad spectrum of women’s health needs. Key areas of his clinical interest include managing Menopause, providing advanced Treatment of Endometriosis, and offering compassionate care for patients experiencing Pelvic Pain.
Professional Affiliations and Memberships
As a testament to his standing in the global medical community, Dr. Kose holds memberships in numerous prestigious professional organizations. These include the European Society of Gynaecological Oncology, the Society of Gynecologic Oncology, and the International Gynecologic Cancer Society, reflecting his dedication to the highest standards in gynecologic cancer care. He is also actively involved with the South Eastern European Robotic Surgery Society and the Society of Robotic Gynecological Surgery, highlighting his interest in minimally invasive techniques. Further affiliations include the Minimally Invasive Gynecologic Oncology Association, the New European Surgical Academy, the Cervical Pathology and Colposcopy Association, the Turkish Obstetrics and Gynecology Association, the Turkish Gynecological Oncology Association, the Middle East and Mediterranean Association of Gynecologic Oncologists, the Turkish German Gynecology Education, Research and Service Foundation, the Turkish Medical Association, and the Trophoblastic Diseases Association. His membership in thealogy Academy also signifies his commitment to specialized women’s health.
Research and Publications
Dr. Kose has made significant contributions to the medical literature, with his research published in esteemed international journals. His work includes investigations into prognostic factors in adult granulosa cell tumors, management strategies for cervical cancer during pregnancy, and the role of lymphadenectomy in endometrial cancer. He has also authored publications on malignant transformation of ovarian teratomas, clinical outcomes of uterine carcinosarcoma, complications following vulvar cancer lymphadenectomy, and the importance of omental metastasis in endometrial cancer. Further research areas include survival benefits of lymphadenectomy in uterine leiomyosarcoma, predictive factors for ovarian neoplasms, and the efficacy of epirubicin in advanced ovarian cancer.